Virus-CKB or the viral-associated disease-specific chemogenomics knowledgebase is a platform created to quickly predict existing FDA-approved drugs which can be repurposed and progress to clinical trials to be used to treat COVID-19. New and effective anti-COVID-19 drugs are in urgent need, but discovering new drugs can take up to 8 years, can cost up to $2 billion and have low approval ratings, hence why re-purposing drugs could be useful. Essentially, the database was created to make viral infection research easier.